1. Home
  2. OCUL vs APPN Comparison

OCUL vs APPN Comparison

Compare OCUL & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • APPN
  • Stock Information
  • Founded
  • OCUL 2006
  • APPN 1999
  • Country
  • OCUL United States
  • APPN United States
  • Employees
  • OCUL N/A
  • APPN N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • APPN Computer Software: Prepackaged Software
  • Sector
  • OCUL Health Care
  • APPN Technology
  • Exchange
  • OCUL Nasdaq
  • APPN Nasdaq
  • Market Cap
  • OCUL 1.8B
  • APPN 2.0B
  • IPO Year
  • OCUL 2014
  • APPN 2017
  • Fundamental
  • Price
  • OCUL $13.60
  • APPN $30.57
  • Analyst Decision
  • OCUL Strong Buy
  • APPN Hold
  • Analyst Count
  • OCUL 6
  • APPN 6
  • Target Price
  • OCUL $17.20
  • APPN $34.40
  • AVG Volume (30 Days)
  • OCUL 2.2M
  • APPN 1.0M
  • Earning Date
  • OCUL 08-05-2025
  • APPN 08-07-2025
  • Dividend Yield
  • OCUL N/A
  • APPN N/A
  • EPS Growth
  • OCUL N/A
  • APPN N/A
  • EPS
  • OCUL N/A
  • APPN N/A
  • Revenue
  • OCUL $56,664,000.00
  • APPN $657,803,000.00
  • Revenue This Year
  • OCUL N/A
  • APPN $15.42
  • Revenue Next Year
  • OCUL $18.87
  • APPN $11.07
  • P/E Ratio
  • OCUL N/A
  • APPN N/A
  • Revenue Growth
  • OCUL N/A
  • APPN 13.67
  • 52 Week Low
  • OCUL $5.79
  • APPN $24.00
  • 52 Week High
  • OCUL $13.82
  • APPN $43.33
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 68.16
  • APPN 56.19
  • Support Level
  • OCUL $12.41
  • APPN $29.40
  • Resistance Level
  • OCUL $12.49
  • APPN $31.17
  • Average True Range (ATR)
  • OCUL 0.56
  • APPN 0.88
  • MACD
  • OCUL 0.04
  • APPN 0.14
  • Stochastic Oscillator
  • OCUL 88.48
  • APPN 79.02

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

Share on Social Networks: